Emerald Health Therapeutics Closes .5 Million Prospectus Sale and Concurrent Secondary Sale

Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), announced today that it closed its prospectus sale (the “Offering”) to a single Canadian institutional accredited investor (the “Investor”), as announced on November 13, 2019. Each Unit consists of one common share of Emerald (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”). READ MORE: https://finance.yahoo.com/news/emerald-health-therapeutics-closes-2-020631244.html?.tsrc=rss The post Emerald Health Therapeutics Closes $2.5 Million Prospectus Sale and Concurrent Secondary Sale appeared first on Cannabis Daily.

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Emerald Health Therapeutics Closes .5 Million Prospectus Sale and Concurrent Secondary Sale
reposted by Cannabis News World